Neurology in Texas

Spark Biomedical Inc is a Dallas-based medical device manufacturer specializing in wearable neurostimulation solutions for complex care scenarios. The company's flagship FDA-cleared product, Sparrow Ascent, utilizes Transcutaneous Auricular Neurostimulation (tAN®) technology to deliver non-invasive, targeted bioelectronic medicine. Primary clinical applications include opioid withdrawal relief and medication reduction, with the platform expanding into neurological health, pediatrics, hemostasis, and women's health. The company conducts clinical trials and collaborates with leading healthcare organizations including the Veterans Administration, Hazelden Betty Ford Foundation, and the National Institutes of Health to advance drug-free treatment options and improve patient outcomes.

Neurofeedback Supply and Equipment of Texas is the exclusive importer and distributor of the NeuronSpectrum line of EEG amplifiers in Texas. The company supplies clinical-grade EEG amplifiers (19–21 channel systems) for quantitative EEG (qEEG) analysis, clinical EEG recording, and neurofeedback training applications. Beyond equipment sales, the company provides comprehensive training and technical support to neurofeedback clinicians—both new and experienced—and assists mental health professionals in establishing brain-based clinical practices. They offer scalable solutions for small to large group practices, including staff selection, training, and practice development services.

NeuFit (operating as Neurological Fitness Equipment and Education LLC) manufactures and distributes the Neubie, an FDA-cleared direct current (DC) electrical stimulation device designed for tissue healing, neuromuscular re-education, and neurological rehabilitation. The Neubie is used across orthopedic recovery, neurological conditions (stroke, spinal cord injury, traumatic brain injury), athletic performance enhancement, and pain management. The company provides a comprehensive methodology called the NeuFit Method, which combines device stimulation with targeted movements and manual techniques to identify neurological limitations, reset dysfunctional patterns through neuroplasticity, and facilitate functional breakthroughs. The platform serves physical therapists, occupational therapists, chiropractors, physicians, athletic trainers, and sports teams. NeuFit reports 400+ clinics, 4,000+ certified practitioners, 75+ professional sports teams, and 15+ universities using the Neubie. Clinical outcomes reported include 90% of users experiencing tangible improvements in the first session, with reductions in pain, increased mobility, improved range of motion, and accelerated recovery timelines. The device is FDA-cleared (510(k)) and subject to US regulatory requirements limiting commercial use to licensed practitioners or under licensed practitioner supervision. The company emphasizes education through practitioner certification programs and provides business support materials for clinical practices incorporating the technology.

InterX Technologies manufactures FDA-cleared, non-invasive neuromodulation devices for the treatment of acute, post-surgical, and chronic neuropathic pain. The company's primary product line includes the InterX® 5002 (professional) and InterX® 1000 (personal) devices, which deliver interactive neurostimulation directly to the skin without conductive gel. Both devices employ patented flex array impedance-seeking electrode pads and are compatible with multiple electrode accessories, including the newly launched XPad®—a flexible, adhesive, cut-to-fit conductive pad for dynamic muscle groups and high-movement zones. InterX devices are used across clinical, sports medicine, military, and home-care settings. The company serves physical therapists, chiropractors, athletic trainers, healthcare professionals, and individual patients. Markets include professional sports (NFL, NBA, MLB, NHL), U.S. military and Veterans Affairs, academic medical centers (Duke Health, Texas Health), and specialized therapy clinics. All devices and accessories are backed by broad patents and clinical evidence. InterX operates training centers and licensing programs for healthcare professionals. The company ships within the United States only.

Epiminder Limited develops and commercializes Minder®, an FDA-authorized implantable continuous EEG monitoring (iCEM®) system for long-term brain activity surveillance. The Minder system is designed to address diagnostic and management challenges in drug-resistant epilepsy by enabling continuous neural monitoring over months to years, compared to traditional scalp EEG monitoring limited to days. The implantable device allows patients to maintain normal daily activities while collecting high-quality EEG data, with remote monitoring capabilities to support clinical assessment and treatment planning. Epiminder targets neurologists and epilepsy centers managing patients with drug-resistant epilepsy, representing approximately 1.1 million adults in the US alone. The company emphasizes evidence-based innovation, clinical validation, and collaboration with the global epilepsy care community. Minder represents a significant advancement in seizure detection and neurological monitoring, extending the diagnostic window and providing actionable data to guide therapeutic interventions.

Multi Bio Sensors Inc. is a US-based manufacturer of medical electrodes specializing in EMG, ECG, and EKG electrodes for clinical and diagnostic applications. Founded over 30 years ago, the company manufactures all products domestically using only US-sourced raw materials and components. The company serves the medical industry with electrode solutions for electrocardiography, electromyography, and related diagnostic procedures. Multi Bio Sensors operates a quick-turnaround manufacturing model and provides quality customer service to both large and small healthcare providers, hospital systems, and diagnostic equipment suppliers. All manufacturing, assembly, and quality control occur in the USA. The company offers both standard electrode products and custom device solutions tailored to customer specifications. Distribution is managed through direct sales and order fulfillment.

Insightec is a medical device manufacturer specializing in incisionless focused ultrasound technology. The company develops and markets Exablate Neuro, an MRI-guided focused ultrasound platform designed for minimally invasive neurosurgical treatment of Essential Tremor and Tremor-dominant Parkinson's Disease. The Exablate Neuro system uses acoustic energy to precisely target and ablate specific areas of the brain (thalamic nucleus) with sub-millimeter precision, guided in real-time by MRI imaging with continuous temperature monitoring. Treatment is typically performed as an outpatient procedure with immediate therapeutic effects and minimal complications. Patients generally return home the same day. The company holds FDA Pre-Market Approval (PMA P150038) for its primary indication and operates globally with headquarters in Israel, US offices in Miami and Dallas, and regional operations in Japan, China, and Europe. Insightec serves neurosurgeons, neurologists, and hospital systems internationally through direct sales and a network of distribution partners. The platform represents an alternative to traditional neurosurgical interventions, offering incision-free, precision-guided treatment with rapid patient recovery.

Surgix Medical is a Texas-based surgical equipment manufacturer established in 2006, specializing in OR efficiency solutions for neurosurgery, spine surgery, and microsurgery. The company manufactures the FusionMAX® Elite Spine Table, a dual-purpose operating table designed to accommodate both cervical and lumbar procedures, reducing OR turnover time through Quick-Change™ radiolucent top systems. Surgix also produces specialized Two-Tier Back Tables and Heavy-Duty sterile drapes (2–3× thicker than standard) designed to maximize limited OR space and minimize drape perforations. The Dan Barrow™ Microsurgical Set, developed by renowned neurosurgeon Dr. Dan Barrow, comprises 36 custom German-made instruments engineered for cranial neurosurgery, featuring proprietary True Balance™ handle technology and custom-designed micro scissors meeting precise ergonomic and tactile feedback standards. The company operates a US-focused distribution network of 95+ surgical sales representatives covering the entire market, and offers new product development services leveraging 60+ years of collective expertise in manufacturing, R&D, regulatory compliance, and sales. Products are positioned for high-volume surgical environments seeking workflow optimization and precision instrumentation.

TeDan Surgical Innovations, Inc. (TSI) is a medical device manufacturer specializing in innovative surgical access systems for spine, neurosurgery, and orthopedic procedures. The company develops and commercializes the Phantom brand of surgical access platforms, including minimally invasive lumbar (MIS), anterior lumbar, anterior cervical, lateral lumbar, and anterior-to-psoas systems for transforaminal, interbody, and lateral fusion approaches. TSI also produces neurosurgical access systems (Phantom TK) for cranial procedures, and manufactures specialized components such as neuromonitoring dilators. The company operates as part of the TSI Group under Halma Group (acquired 2023), which includes West Coast Surgical and Axcess Surgical subsidiaries. TSI provides vertically integrated contract development and manufacturing organization (CDMO+) services to spine OEM partners, offering precision machining, full product development, regulatory strategy, and manufacturing scalability. The company maintains manufacturing capacity in the United States and has expanded internationally, including a German subsidiary (TeDan Surgical Innovations GmbH). TSI focuses on surgeon-centered design, reproducible workflows, and improved intraoperative visualization. Products are engineered for simplicity, versatility, and assembly stability in complex spine and neurosurgical environments. The company engages actively in professional medical conferences (AANS, AO) and maintains partnerships with leading surgeon innovators.

Stratus (Alliance Neurodiagnostics, LLC) is a leading US provider of electroencephalography (EEG) solutions and services. The company delivers comprehensive end-to-end EEG services including ambulatory (at-home) video EEG testing, continuous EEG (cEEG) monitoring for ICU and epilepsy monitoring units (EMU), clinical trial support with decentralized and multi-site testing options, EEG hardware for inpatient and in-office use, and proprietary StratusEEG software for clinical workflow management and data analysis. Stratus serves thousands of clinicians across major U.S. healthcare systems, monitoring over 2 million patients remotely monthly and providing over 2.2 million hours of anonymized EEG data through their research division. The company integrates AI and deep learning algorithms to streamline EEG data analysis and support clinical decision-making without replacing clinician expertise. Stratus holds The Joint Commission accreditation and SOC 2 Type 2 certification, demonstrating commitment to quality and data security. The company is recognized as the #1 ambulatory EEG software provider in the United States and offers all-purpose EEG software in Scandinavia. Services extend to biomarker detection and research partnerships with leading healthcare organizations.

IDMED develops and markets innovative medical devices for anesthesia and intensive care monitoring. The company specializes in automated pupillometry and neuromuscular transmission (NMT) monitoring solutions used globally in operating rooms and ICU settings. The NeuroLight® pupillometer provides accurate, automated measurement of pupil size and reactivity for neurological assessment and prognostication in intensive care environments. The ToFscan® is a quantitative neuromuscular blockade monitor utilizing three-dimensional sensors with a wide sensor range and requires no pre-use calibration. Both products are designed to enhance clinical decision-making and patient safety in perioperative and critical care settings. IDMED's focus on neurological and neuromuscular monitoring positions the company within the specialty diagnostic and patient monitoring equipment segment, serving anesthesiology, critical care, and neurology departments.

Electromedical Products International (EPII) manufactures Alpha-Stim®, a family of FDA-cleared cranial electrotherapy stimulation (CES) devices for treatment of anxiety, insomnia, depression, and acute/chronic pain without medication. The company offers two primary product lines: Alpha-Stim M (a wearable electrotherapy device approved for anxiety, insomnia, depression, and pain management) and Alpha-Stim AID (designed for anxiety, insomnia, and depression). Alpha-Stim devices deliver low-level electrical microcurrent to the brain via ear clip electrodes, providing drug-free symptom relief suitable for both clinical and home settings. Products are prescribed by healthcare professionals globally and marketed directly to patients through their online store and telehealth consultation platform. The company supports clinical adoption with patient education resources, provider demos, and customer support services including product registration, warranty, and returns. EPII operates a customer service center accessible by phone (1-800-367-7246 / +940-328-0788) and email. The device platform targets anxiety disorders, sleep disturbances, depression (outside US), and pain management across diverse patient populations including active-duty military, first responders, and general wellness consumers. Manufacturing and regulatory credentials include FDA 510(k) clearance for marketed indications.

Fiagon GmbH is a manufacturer of electromagnetic navigation systems for ENT (otorhinolaryngology), sinus surgery, ear surgery, and cranio-maxillofacial (CMF) procedures. The company specializes in image-guided surgical navigation technology that enables precise, minimally invasive surgical planning and execution. Their product portfolio includes the Cube 4D Navigation System, which employs electromagnetic navigation to facilitate complex and routine otolaryngological procedures with high safety and efficiency. Fiagon also offers VirtuEye, a contactless photo registration system for patient positioning and registration completed in under one minute, designed for intuitive use across multiple surgical team members. The company manufactures flexible navigation instruments including PointerShells, FlexTubes, and FlexPointers that adapt to patient anatomy while enabling simultaneous functional capabilities such as suction and palpation. Their instruments support integration with standard surgical tools and burrs for comprehensive navigational guidance. Fiagon has received multiple innovation awards (Innovation of the Year 2016, Top Innovator 2015, Innovator of the Year 2014), indicating recognition within the surgical technology sector. The company serves hospitals and surgical centers globally with products designed to improve surgical accuracy and reduce operative time in complex head and neck procedures. Specific regulatory certifications and 510(k) status information were not visible in the provided content.

Orthofix is a global medical device company specializing in orthopedic and spinal reconstruction solutions. The company manufactures a comprehensive portfolio of products and therapies addressing spinal conditions, limb reconstruction, and bone healing. Key product lines include spine fusion hardware and biologics (OsteoCove putty), bone growth stimulation therapies (AccelStim, CervicalStim, SpinalStim), limb reconstruction systems for congenital and acquired deformities, and the 7D FLASH surgical navigation platform—a machine-vision-enabled system offering radiation-free 3D image guidance for spine and cranial procedures. Orthofix's approach integrates mechanical, biological, and electromagnetic treatment modalities. The 7D FLASH system features streamlined registration (30 seconds vs. 30 minutes), sterile-field control, and superior surgical precision. The company serves orthopedic surgeons, spine surgeons, and orthopedic trauma specialists globally, with established clinical evidence and medical education programs supporting the complete patient pathway. Manufacturing and R&D capabilities are documented through product development initiatives and regulatory submissions. Orthofix maintains ISO and regulatory compliance appropriate to medical device classifications and operates manufacturing facilities supporting international distribution.

MicroTransponder Inc., operating under the brand Vivistim, manufactures FDA-approved breakthrough vagus nerve stimulation (VNS) therapy systems for post-stroke upper limb recovery. The Vivistim system is a wearable neuromodulation device designed to be paired with occupational and physical therapy to enhance neuroplasticity and improve hand and arm function in chronic ischemic stroke survivors. The device delivers targeted vagal stimulation during rehabilitation exercises and daily activities, clinically demonstrated to provide 2–3 times greater improvement in upper limb function compared to intensive therapy alone. FDA-cleared as a breakthrough device for safety and efficacy, the system targets a significant market of stroke survivors with persistent upper limb impairment. The company operates a patient qualification and enrollment model, working with rehabilitation specialists and therapy centers. Clinical evidence supports high user satisfaction (98%) and lasting functional improvements with sustained reduction in impairment. The company partners with leading stroke advocacy and occupational therapy organizations, indicating strong clinical and professional credibility in the neurorehabilitation space.

NeuroDynamics Global Inc manufactures and distributes an FDA-cleared Class II neuromodulation medical device for the treatment of painful diabetic neuropathy (PDN). The company's primary offering is a minimally invasive, temporary-wear neuromodulation system delivered through a 20-day in-office protocol designed to reduce chronic neuropathic pain associated with diabetes. The device represents a non-pharmacologic, non-opioid alternative to conventional pain management approaches. NeuroDynamics operates a turnkey provider program that includes comprehensive training, clinical liaison support, revenue cycle management, reimbursement navigation, and outcomes tracking tools. The therapy is positioned for multi-specialty adoption across neurology, pain management, endocrinology, and primary care settings. The company manages insurance coverage coordination and payer-specific reimbursement processes. Manufacturing and regulatory compliance meet FDA Class II standards for neuromodulation devices. The operational model emphasizes rapid practice integration, with providers able to begin treating PDN patients within weeks of program enrollment. The device is indicated for durable pain relief in diabetic neuropathy patients and is covered by many insurance plans, though coverage remains payer- and patient-specific.

Mind Media Group manufactures and supplies EEG-based neurotechnology platforms for clinical, research, and educational applications. The company's core product line is the NeXus system—a multimodal biosensor platform available in wireless configurations (NeXus 10 MK3, NeXus Q24, NeXus Q32)—designed for nervous system sensing and real-time biofeedback/neurofeedback training. NeXus integrates EEG acquisition with sensors for physiological measurement (heart rate variability, skin conductance, respiration) and connects to Biotrace+, proprietary software for quantitative EEG (qEEG), biofeedback protocols, and neurofeedback applications. The platform serves three primary markets: clinical practice (mind-body assessments, therapeutic training for PTSD, ADHD, anxiety, depression), research (3000+ peer-reviewed publications), and education (certification and practitioner development). Complementary offerings include EEG caps, sensors, and cables. The company is widely adopted by major medical centers (Mayo Clinic, Cleveland Clinic, Kaiser Permanente), military and VA health systems (Walter Reed, multiple VA facilities, Department of Defense), academic institutions (MIT, Harvard, Max Planck Institute), and specialized centers (Rady Children's Hospital, Schön Klinik). Mind Media provides comprehensive training and education through its Path to Mastery Academy, offering courses from biofeedback basics through certified practitioner certification. The platform supports clinical assessment, performance optimization, and neuroscience research. Regulatory status, ISO certifications, and FDA classification status are not explicitly stated in available content.

MedCAD is a Dallas-based medical technology company founded in 2007, specializing in patient-matched surgical devices and virtual surgical planning solutions. The company leverages advanced 3D imaging, CAD software, and precision manufacturing to design customized implants, surgical guides, and anatomical models for complex reconstructive and corrective procedures. Core offerings include the AccuPlan® Surgical Planning System for virtual surgical design, AccuPlate® 3D-printed titanium reconstruction plates, AccuShape® cranial implants in PEEK or titanium, AccuModel® anatomical models for surgical visualization, and AccuStride® foot and ankle surgical solutions. MedCAD serves cranial, maxillofacial, orthognathic, oral, plastic, and orthopedic surgery specialties. The company manufactures in-house in Texas with FDA clearance for its surgical products. MedCAD's approach combines engineer and design expertise—including trained sculptors and product designers—to create precision instruments and implants tuned to individual patient anatomy, enabling surgeons to plan procedures virtually, reduce operative time, and improve clinical outcomes.

Nexalin Technology manufactures a non-invasive, drug-free medical device for transcranial electrical stimulation (TES) targeting anxiety, depression, and insomnia. The device delivers a patented waveform that stimulates deep midbrain structures to normalize neurochemical imbalances, particularly increasing beta-endorphins and modulating serotonin and dopamine levels. FDA-classified as a non-significant risk device, it delivers 40-minute home-based treatments with no reported side effects. Clinical data indicates 60–80% symptom reduction rates. The company markets to both healthcare providers seeking to establish virtual treatment clinics and direct-to-consumer patients. The technology addresses the growing mental health epidemic in the United States through an evidence-based, medication-free alternative.

Phasor Health manufactures FDA-cleared, single-use, disposable cranial and surgical drills for neurosurgery, spine, and orthopedic applications. The company specializes in electric and manual (hand-crank) cranial access drills with proprietary anti-plunging safety technology—a 50-pound-tested mechanical stopper validated in 25,000+ clinical cases with zero reported plunges when properly used. Product portfolio includes the 5-in-1 Cranial Access Drill (for EVD and ICP monitor placement), single-bit drills, longer-bit variants for biopsy and spine applications, the Phasor EVAC minimally-invasive chronic subdural evacuation system, EZ Fiducials bone markers for image guidance, and the Phasor Legacy manual drill. All products are manufactured in-house at their US facility with no outsourcing, enabling same or next-business-day delivery even during industry shortages. The company holds over 250 hospital accounts including Level I trauma centers and is contracted with HealthTrust Performance Group, Premier, and SAM.gov. Manufacturing and R&D capabilities support both single-use and reusable options across burr hole, craniotomy, spine, and orthopedic extremity indications. Regulatory status includes FDA 510(k) clearance for disposable power drills.

Neuromersive Inc (operating as Neuro Rehab VR) is an FDA-registered, HIPAA-compliant virtual reality healthcare technology company specializing in AI-powered immersive XR therapy systems for neurological rehabilitation. Founded in 2017 and based in Fort Worth, Texas, the company develops the Smart Therapy™ Complete Solution—an integrated platform combining VR headsets, motion controllers, clinician tablets, and comprehensive software libraries for evidence-based therapy exercises. The system addresses upper and lower extremity rehabilitation, cognitive therapy, pain management, and anxiety relief through engaging 3D immersive applications. The platform includes an AI-powered analytics portal for real-time progress tracking, automated therapy documentation, and patient management. Clinical evidence demonstrates 92% improvement in patient motivation, 85% pain reduction, 50% reduction in documentation time, and 35% increase in billing ROI. Trusted by major healthcare systems including Cedars-Sinai, MD Anderson, Kaiser Permanente, Penn Medicine, Ascension, and the U.S. Veterans Affairs, Neuro Rehab VR has delivered therapy to over 350 patients across thousands of sessions. The solution serves hospitals, outpatient clinics, skilled nursing facilities, and government healthcare providers.